Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

ULTRAVIST Safety Reports

Total ULTRAVIST reports: 376.
ULTRAVIST FDA safety alerts: 2006 .
Reported deaths: 54    Reported hospitalizations: 171.
Take ULTRAVIST Side Effects Survey or Share Your ULTRAVIST Story. Read More Here.

Showing 1-75 of 376 Next >

Physician from GERMANY reported ULTRAVIST problem on Mar 23, 2007. Female patient, 73 years of age, was diagnosed with diabetes mellitus, hypertension, polyneuropathy and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, renal failure acute, renal tubular necrosis, shock. ULTRAVIST dosage: 100 ML, 1 DOSE. During the same period patient was treated with INSULIN, METFORMIN, COAPROVEL, GABAPENTIN, GASTROGRAFIN. Patient was hospitalized. Patient died on 04/03/2006.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, 52 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, loss of consciousness, multi-organ failure, pulse absent. ULTRAVIST dosage: APPROX. 150 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

Health Professional from CHINA reported ULTRAVIST problem on Mar 23, 2007. Male patient, 40 years of age, weighting 132.3 lb, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, blood pressure immeasurable, cyanosis, loss of consciousness, rash. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from CHINA on Mar 23, 2007. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, blood pressure decreased, rash. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on Mar 23, 2007. Female patient, 45 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, pulse pressure decreased. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient died on 03/23/2007.

ULTRAVIST problem was reported by a Consumer or non-health professional from POLAND on Mar 21, 2007. Male patient, 18 years of age, weighting 127.9 lb, was diagnosed with computerised tomogram head and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: extrasystoles, loss of consciousness, pallor, peripheral coldness, pruritus, pulse absent, skin burning sensation. ULTRAVIST dosage: 50 ML, 1 DOSE. During the same period patient was treated with VINPOCETINE. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on Mar 26, 2007. Male patient, 55 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, confusional state, convulsion, dyspnoea, rash, urinary incontinence. ULTRAVIST dosage: 120 ML, 1 DOSE. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from CHINA on Mar 26, 2007. Female patient, 70 years of age, weighting 154.3 lb, was diagnosed with computerised tomogram, hypertension and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. ULTRAVIST dosage: 80 ML, 1 DOSE. During the same period patient was treated with METOPROLOL SUCCINATE. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Mar 27, 2007. Female patient, 42 years of age, was diagnosed with computerised tomogram abdomen, coagulopathy and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: pulmonary hypertension, renal failure, right ventricular failure. ULTRAVIST dosage: unknown. During the same period patient was treated with FRESH FROZEN PLASMA, VITAMIN K, RED BLOOD CELLS, FLOLAN. Patient was hospitalized. Patient died on 07/18/2006.

ULTRAVIST problem was reported by a Health Professional from CHINA on Mar 29, 2007. Male patient, 45 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure decreased, loss of consciousness, nausea, shock. ULTRAVIST dosage: 85 ML, 1 DOSE. Patient recovered.

Consumer or non-health professional from KOREA, REPUBLIC OF reported ULTRAVIST problem on Mar 28, 2007. Female patient, 57 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. ULTRAVIST dosage: 120 ML, 1 DOSE. Patient died on 03/21/2007.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Male patient, 73 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: agitation, anaphylactic reaction, cardiac arrest, foaming at mouth, hypertensive crisis, pulmonary oedema, stridor. ULTRAVIST dosage: 150 ML, 1 DOSE. During the same period patient was treated with CONTRAST MEDIA. Patient was hospitalized. Patient recovered.

Physician from CHINA reported ULTRAVIST problem on Apr 03, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with computerised tomogram kidney and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: shock, tachycardia, vision blurred. ULTRAVIST dosage: 90 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Apr 03, 2007. Male patient, 75 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. ULTRAVIST dosage: 125 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported ULTRAVIST problem on Apr 12, 2007. Male patient, 76 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, angioedema, cardiac arrest, coma, cough, erythema, loss of consciousness, throat irritation. ULTRAVIST dosage: 40 ML, UNK. Patient was hospitalized. Patient died on 02/17/2007.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Apr 13, 2007. Female patient, 59 years of age, weighting 119.0 lb, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: choking sensation, dysphagia, dyspnoea, eyelid oedema, nasal congestion, rash, sneezing. ULTRAVIST dosage: 50 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported ULTRAVIST problem on Apr 19, 2007. Male patient, 76 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, angioedema, cardiac arrest, coma, cough, erythema, loss of consciousness, throat irritation. ULTRAVIST dosage: 40 ML, UNK. Patient was hospitalized. Patient died on 02/17/2007.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Apr 26, 2007. Female patient, 84 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: chills, post procedural complication. ULTRAVIST dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Apr 26, 2007. Female patient, 33 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: hypotension, hypoxia. ULTRAVIST dosage: unknown. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Apr 26, 2007. Male patient, child 6 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, swelling. ULTRAVIST dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Apr 26, 2007. Female patient, 57 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, no therapeutic response. ULTRAVIST dosage: unknown. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from AUSTRALIA on Apr 27, 2007. Female patient was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: bronchospasm, rash, respiratory arrest. ULTRAVIST dosage: unknown. Patient recovered.

Pharmacist from FRANCE reported ULTRAVIST problem on Apr 18, 2007. Male patient, 74 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dyspnoea, hyperhidrosis, hypertonia, loss of consciousness, pulse abnormal. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED KINGDOM on Apr 18, 2007. Female patient, 71 years of age, weighting 198.4 lb, was diagnosed with fibromyalgia and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cystitis, diarrhoea, fibromyalgia, injection site pain, vomiting. ULTRAVIST dosage: 100 ML, 1 DOSE. During the same period patient was treated with ATENOLOL, CITALOPRAM HYDROBROMIDE. Patient recovered.

Pharmacist from GERMANY reported ULTRAVIST problem on Apr 24, 2007. Male patient, 75 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, depressed level of consciousness, dyspnoea, feeling abnormal, procedural complication, pulmonary embolism, superior vena caval occlusion. ULTRAVIST dosage: 100 ML, 1 DOSE. During the same period patient was treated with PANTOZOL. Patient died.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Female patient, 66 years of age, weighting 119.0 lb, was diagnosed with hypertension and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, dizziness, electrocardiogram qt prolonged, flushing, headache, heart rate increased, hypotension, lip swelling, rash erythematous. ULTRAVIST dosage: 81 ML, 1 DOSE. During the same period patient was treated with READI, LISINOPRIL, LIPITOR, ASPIRIN, VITAMIN CAP, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Pharmacist from GERMANY reported ULTRAVIST problem on Apr 30, 2007. Male patient, 75 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, depressed level of consciousness, dyspnoea, feeling abnormal, pulmonary embolism. ULTRAVIST dosage: 100 ML, 1 DOSE. During the same period patient was treated with PANTOZOL. Patient died.

ULTRAVIST problem was reported by a Health Professional from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with arthrogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: arthralgia. ULTRAVIST dosage: 5 ML, 1 DOSE. During the same period patient was treated with MAGNEVIST, LIGNOCAINE. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on May 08, 2007. Male patient, 54 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. ULTRAVIST dosage: unknown. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from GERMANY on May 07, 2007. Female patient, 34 years of age, weighting 160.9 lb, was diagnosed with angiogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, dyspnoea, feeling hot, hypersensitivity, micturition urgency, oedema mucosal, restlessness, skin swelling, swollen tongue. ULTRAVIST dosage: 20 ML, 1 DOSE. During the same period patient was treated with METHYLPREDNISOLONE, FENISTIL, TYZANOL. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on May 16, 2007. Female patient, 51 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: feeling cold, hyperhidrosis, shock, urinary incontinence. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on May 17, 2007. Female patient, 57 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, nausea, vomiting. ULTRAVIST dosage: 120 ML, 1 DOSE. Patient died on 03/21/2007.

Physician from ITALY reported ULTRAVIST problem on May 16, 2007. Female patient, 49 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, urticaria. ULTRAVIST dosage: unknown. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from ITALY on May 16, 2007. Male patient, 57 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: flushing, hypovolaemic shock. ULTRAVIST dosage: 120 ML, 1 DOSE. Patient recovered.

Health Professional from ITALY reported ULTRAVIST problem on May 16, 2007. Female patient, 73 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, face oedema, malaise. ULTRAVIST dosage: 120 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Physician from ITALY on May 16, 2007. Female patient, 27 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, arrhythmia, bradycardia, hypotension, loss of consciousness. ULTRAVIST dosage: 10 ML. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on May 28, 2007. Female patient, 51 years of age, weighting 121.3 lb, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, asthenia, blood pressure decreased, convulsion, heart rate increased, hyperhidrosis, hypoaesthesia, nausea, vomiting. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 21, 2007. Female patient was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. ULTRAVIST dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported ULTRAVIST problem on May 25, 2007. Male patient, 83 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: renal failure. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient died on 02/01/2007.

ULTRAVIST problem was reported by a Physician from FRANCE on May 24, 2007. Male patient, 76 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, angioedema, cardiac arrest, coma, cough, erythema, loss of consciousness, throat irritation. ULTRAVIST dosage: 40 ML, UNK. During the same period patient was treated with PREVISCAN, ALLOPURINOL, AMLOR, AMIODARONE HYDROCHLORIDE, MICARDIS. Patient was hospitalized. Patient died on 02/17/2007.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on May 29, 2007. Female patient, 51 years of age, weighting 121.3 lb, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, asthenia, blood pressure decreased, convulsion, heart rate increased, hyperhidrosis, hypoaesthesia, nausea, vomiting. ULTRAVIST dosage: 100 ML, 1 DOSE. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on May 22, 2007. Female patient, 74 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, dyspnoea, erythema, feeling hot, sneezing, unresponsive to stimuli. ULTRAVIST dosage: 89 ML, 1 DOSE. During the same period patient was treated with READI, LEXAPRO, DIOVAN, DUONEB, ALBUTEROL. Patient died on 05/21/2007.

Consumer or non-health professional from CZECH REPUBLIC reported ULTRAVIST problem on May 25, 2007. Male patient, 69 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: angina pectoris, dyspnoea, hyperhidrosis, pharyngolaryngeal pain, somnolence, sopor. ULTRAVIST dosage: unknown. During the same period patient was treated with LOZAP. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Physician from POLAND on May 29, 2007. Female patient, 20 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. ULTRAVIST dosage: unknown. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on June 04, 2007. Female patient was diagnosed with computerised tomogram and was treated with ULTRAVIST. ULTRAVIST dosage: 50 ML, 1 DOSE. Patient died on 05/28/2007.

ULTRAVIST problem was reported by a Pharmacist from GERMANY on June 01, 2007. Male patient, 75 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, depressed level of consciousness, feeling abnormal, hyperaemia, hyperhidrosis, respiratory failure. ULTRAVIST dosage: 100 ML, 1 DOSE. During the same period patient was treated with PANTOZOL. Patient died on 04/24/2007.

Health Professional from UNITED KINGDOM reported ULTRAVIST problem on June 08, 2007. Male patient was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: respiratory arrest, vomiting. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED KINGDOM on June 12, 2007. Female patient was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: contrast media reaction. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported ULTRAVIST problem on June 12, 2007. Female patient was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: contrast media reaction. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from CHINA on June 19, 2007. Female patient, 35 years of age, weighting 125.7 lb, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, lip oedema, shock. ULTRAVIST dosage: unknown. Patient recovered.

Consumer or non-health professional from CHINA reported ULTRAVIST problem on June 20, 2007. Female patient, 74 years of age, was diagnosed with arteriogram coronary and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: coma, shock. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED KINGDOM on June 20, 2007. Male patient, 73 years of age, was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: bronchospasm, respiratory arrest, vomiting. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from THAILAND reported ULTRAVIST problem on June 23, 2006. Male patient, 64 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, muscle spasms, pulse absent, respiratory arrest. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Physician from HUNGARY on June 20, 2006. Female patient, 71 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, aneurysm, anuria, asthenia, atelectasis, blood pressure increased, bronchiolitis, bronchitis, cardiopulmonary failure. ULTRAVIST dosage: 50 ML, 1 DOSE, X 10, INTRAVENOUS. Patient was hospitalized. Patient died on 05/20/2006.

Consumer or non-health professional from AUSTRALIA reported ULTRAVIST problem on June 19, 2006. Female patient, 29 years of age, was diagnosed with angiogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, cerebrovascular accident, procedural complication. ULTRAVIST dosage: unknown. Patient recovered.

ULTRAVIST problem was reported by a Pharmacist from UNITED STATES on July 06, 2006. Male patient, 66 years of age, weighting 0.16 lb, was diagnosed with catheterisation cardiac and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, chest pain, heart rate abnormal, oedema peripheral, orbital oedema, oxygen saturation decreased, procedural complication, procedural hypotension. ULTRAVIST dosage: 175 ML IV X 1. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ULTRAVIST problem on June 27, 2006. Male patient was diagnosed with computerised tomogram abdomen, nuclear magnetic resonance imaging and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, depressed level of consciousness, diabetes mellitus inadequate control, dialysis, fluid overload, glasgow coma scale abnormal, intestinal infarction, malaise, miosis. ULTRAVIST dosage: ML. During the same period patient was treated with GADOVIST, NALOXONE. Patient was hospitalized. Patient died on 06/28/2005.

ULTRAVIST problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 27, 2006. Male patient was diagnosed with computerised tomogram abdomen, multiple sclerosis, nuclear magnetic resonance imaging and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, depressed level of consciousness, diabetes mellitus inadequate control, dialysis, fluid overload, glasgow coma scale abnormal, intestinal infarction, malaise, miosis. ULTRAVIST dosage: ML. During the same period patient was treated with GADOVIST, NALOXONE. Patient was hospitalized. Patient died on 06/28/2005.

Health Professional from UNITED STATES reported ULTRAVIST problem on June 29, 2006. Male patient, 72 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: foaming at mouth, respiratory distress, skin discolouration, urticaria localised. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient recovered.

ULTRAVIST problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Female patient, 63 years of age, weighting 187.0 lb, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: blister, erythema, oedema peripheral, post procedural complication, pruritus, scar. ULTRAVIST dosage: unknown. During the same period patient was treated with DONADOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ULTRAVIST problem on June 28, 2006. Female patient, 65 years of age, weighting 250.0 lb, was diagnosed with arteriogram coronary and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: contrast media reaction, dysphonia, intubation complication, respiratory arrest, swollen tongue, urticaria. ULTRAVIST dosage: unknown. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Physician from UNITED STATES on June 28, 2006. Male patient, 43 years of age, was diagnosed with angiogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, depressed level of consciousness, dyspnoea, feeling abnormal, malaise, pruritus. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient recovered.

Physician from PORTUGAL reported ULTRAVIST problem on July 10, 2006. Female patient, 71 years of age, weighting 176.4 lb, was diagnosed with scan with contrast and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, contrast media reaction. ULTRAVIST dosage: 150 ML, 1 DOSE, INTRAVENOUS. Patient recovered.

ULTRAVIST problem was reported by a Physician from ITALY on July 11, 2006. Male patient, 76 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, dyspnoea, feeling hot, hyperhidrosis, hypersensitivity, nausea. ULTRAVIST dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on July 07, 2006. Male patient, 49 years of age, was diagnosed with computerised tomogram abdomen, computerised tomogram thorax and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, laryngeal oedema, pruritus, sneezing. ULTRAVIST dosage: 150 ML, 1 DOSE, INTRAVENOUS. Patient died on 06/28/2006.

ULTRAVIST problem was reported by a Health Professional from UNITED KINGDOM on July 13, 2006. Female patient, 44 years of age, weighting 163.1 lb, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, dermatitis exfoliative, nausea, vomiting. ULTRAVIST dosage: unknown. During the same period patient was treated with HYDROXYCHLOROQUINE SULPHATE. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Nov 22, 2005. Female patient, 48 years of age, weighting 170.0 lb, was diagnosed with computerised tomogram thorax and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: bradycardia, burning sensation, chest pain, chills, dyspnoea, face oedema, hypotension, mucous membrane disorder, tremor. ULTRAVIST dosage: 150 ML, 1 DOSE, INTRAVENOUS. During the same period patient was treated with NEURONTIN, FLEXERIL, DEPAKOTE, LOVENOX. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Aug 29, 2005. Male patient, 80 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: dyspnoea. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Aug 29, 2005. Female patient, 62 years of age, was diagnosed with computerised tomogram thorax and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, throat tightness. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Male patient was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: dyspnoea, throat irritation. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient recovered.

Physician from UNITED STATES reported ULTRAVIST problem on Aug 02, 2005. Female patient, 68 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: choking sensation, dizziness, flushing, urticaria. ULTRAVIST dosage: 150 ML, 1 DOSE, INTRAVENOUS. During the same period patient was treated with HYDROCODONE BITARTRATE, CIPRO, ATENOLOL. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on May 19, 2005. Female patient, 40 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: choking sensation. ULTRAVIST dosage: 96 ML, 1 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Aug 01, 2005. Male patient, 76 years of age, was diagnosed with arteriogram coronary and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: feeling hot, hypotension. ULTRAVIST dosage: 25 ML, 1 DOSE, INTRA-ARTERIAL. During the same period patient was treated with ZETIA, ZOCOR, ASPIRIN, VALIUM, BENADRYL. Patient was hospitalized. Patient recovered.

ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Sept 07, 2005. Female patient, 47 years of age, weighting 170.0 lb, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, respiratory distress, vomiting. ULTRAVIST dosage: 150 ML, 1 DOSE, INTRAVENOUS. Patient recovered.

Health Professional from UNITED STATES reported ULTRAVIST problem on Aug 08, 2005. Male patient, 52 years of age, was diagnosed with computerised tomogram abdomen and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: dyspnoea, erythema. ULTRAVIST dosage: 100 ML, 1 DOSE, INTRAVENOUS. Patient recovered.

Showing 1-75 of 376 Next >